Show simple item record

dc.contributor.advisorFalconer, Robert A.
dc.contributor.advisorLoadman, Paul
dc.contributor.authorBanisalman, Katreen A.F.
dc.date.accessioned2024-03-28T13:03:29Z
dc.date.available2024-03-28T13:03:29Z
dc.date.issued2021
dc.identifier.urihttp://hdl.handle.net/10454/19857
dc.language.isoenen_US
dc.rights<a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>.eng
dc.subjectCanceren_US
dc.subjectMT1-MMPen_US
dc.subjectProdrugen_US
dc.subjectVascular disrupting agent (VDA)en_US
dc.subjectColchicineen_US
dc.subjectAnti-cancer prodrugsen_US
dc.titleSynthesis and biological evaluation of MMP-activated anti-cancer prodrugsen_US
dc.type.qualificationleveldoctoralen_US
dc.publisher.institutionUniversity of Bradfordeng
dc.publisher.departmentFaculty of Life Sciencesen_US
dc.typeThesiseng
dc.type.qualificationnamePhDen_US
dc.date.EndofEmbargo2027-03-28
dc.date.awarded2021
dc.description.publicnotesThe full text will be available at the end of the embargo period: 28th March 2027en
refterms.dateFOA2024-03-28T13:03:29Z


Item file(s)

Thumbnail
Name:
17019571 Katreen Banisalman Final ...
Embargo:
2027-03-25
Size:
5.690Mb
Format:
PDF
Description:
PhD Thesis

This item appears in the following Collection(s)

Show simple item record